Ali Azargoonjahromi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 20

Top Topics

Systematic Review

Blood Brain Barrier

Mild Cognitive Impairment

Cerebral Ischemia

Top Venues

Molecular brain

Viral immunology

Clinical drug investigation

Nutrition & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Ali Azargoonjahromi
Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline. The Journal of pharmacy and pharmacology 76 (9) (2024)
Ali Azargoonjahromi
Role of the SARS-CoV-2 Virus in Brain Cells. Viral immunology 37 (2) (2024)
Ali Azargoonjahromi
The duality of amyloid-β: its role in normal and Alzheimer's disease states. Molecular brain 17 (1) (2024)
Ali Azargoonjahromi
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment. Clinical drug investigation (2024)
Mohammad Sadeghi, Ali Azargoonjahromi, Hamide Nasiri, Arash Yaghoobi, Maryam Sadeghi, Seyedeh Saeideh Chavoshi, Shilan Baghaeikia, Nastaran Mahzari, Arina Valipour, Romina Razeghi Oskouei, Farshad Shahkarami, Fatemeh Amiri, Mahsa Mayeli
Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study. Molecular brain 17 (1) (2024)
Ali Azargoonjahromi, Fatemeh Abutalebian, Fatemeh Hoseinpour
The role of resveratrol in neurogenesis: a systematic review. Nutrition reviews (2024)
Ali Azargoonjahromi
Role of the SARS-CoV-2 Virus in Brain Cells. Viral immunology 37 (2) (2024)
Ali Azargoonjahromi
Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline. The Journal of pharmacy and pharmacology (2024)
Mohammad Sadeghi, Ali Azargoonjahromi, Hamide Nasiri, Arash Yaghoobi, Maryam Sadeghi, Seyedeh Saeideh Chavoshi, Shilan Baghaeikia, Nastaran Mahzari, Arina Valipour, Romina Razeghi Oskouei, Farshad Shahkarami, Fatemeh Amiri, Mahsa Mayeli
Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study. Molecular brain 17 (1) (2024)
Ali Azargoonjahromi
The duality of amyloid-β: its role in normal and Alzheimer's disease states. Molecular brain 17 (1) (2024)
Ali Azargoonjahromi
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment. Clinical drug investigation 44 (7) (2024)
Ali Azargoonjahromi, Fatemeh Abutalebian
Unraveling the therapeutic efficacy of resveratrol in Alzheimer's disease: an umbrella review of systematic evidence. Nutrition & metabolism 21 (1) (2024)
Ali Azargoonjahromi
Role of the SARS-CoV-2 Virus in Brain Cells. Viral immunology 37 (2) (2024)
Ali Azargoonjahromi
The duality of amyloid-β: its role in normal and Alzheimer's disease states. Molecular brain 17 (1) (2024)
Ali Azargoonjahromi
Role of the SARS-CoV-2 Virus in Brain Cells. Viral immunology (2024)
Ali Azargoonjahromi, Fatemeh Abutalebian
Unraveling the therapeutic efficacy of resveratrol in Alzheimer's disease: an umbrella review of systematic evidence. Nutrition & metabolism 21 (1) (2024)
Ali Azargoonjahromi, Fatemeh Abutalebian
Unraveling the therapeutic efficacy of resveratrol in Alzheimer's disease: an umbrella review of systematic evidence. Nutrition & metabolism 21 (1) (2024)
Ali Azargoonjahromi
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment. Clinical drug investigation 44 (7) (2024)
Ali Azargoonjahromi
The role of epigenetics in anxiety disorders. Molecular biology reports (2023)
Ali Azargoonjahromi
A systematic review of the association between zinc and anxiety. Nutrition reviews (2023)